MedPath

成都奥邦药业有限公司

Ownership
-
Established
2015-01-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Tandospirone Citrate Tablets

Product Name
枸橼酸坦度螺酮片
Approval Number
国药准字H20244492
Approval Date
Jul 30, 2024
NMPA

Tandospirone Citrate Tablets

Product Name
枸橼酸坦度螺酮片
Approval Number
国药准字H20244491
Approval Date
Jul 30, 2024
NMPA

Terbinafine Hydrochloride Tablets

Product Name
盐酸特比萘芬片
Approval Number
国药准字H20094133
Approval Date
Feb 6, 2024
NMPA

Terbutaline Sulfate Nebuliser Solution

Product Name
硫酸特布他林雾化吸入用溶液
Approval Number
国药准字H20234595
Approval Date
Dec 5, 2023
NMPA

Anethel Trithione Tablets

Product Name
茴三硫片
Approval Number
国药准字H51023567
Approval Date
Aug 17, 2023
NMPA

Anethel Trithione Tablets

Product Name
茴三硫片
Approval Number
国药准字H51023568
Approval Date
Aug 17, 2023
NMPA

Ferrous Succinate Tablets

Product Name
琥珀酸亚铁片
Approval Number
国药准字H20083003
Approval Date
Jul 25, 2022
NMPA

Meclofenoxate Hydrochloride

Product Name
盐酸甲氯芬酯
Approval Number
国药准字H20073946
Approval Date
Jul 13, 2022
NMPA

Loratadine

Product Name
氯雷他定
Approval Number
国药准字H20060953
Approval Date
Mar 15, 2021
NMPA

Berberine Hydrochloride

Product Name
盐酸小檗碱
Approval Number
国药准字H51021460
Approval Date
Mar 15, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.